4.3 Article

Glycaemic control and body mass index in late-adolescents and young adults with Type 1 diabetes mellitus: a population-based study

期刊

DIABETIC MEDICINE
卷 25, 期 3, 页码 360-364

出版社

WILEY
DOI: 10.1111/j.1464-5491.2007.02372.x

关键词

adolescence; Type 1 diabetes; HbA(1c); BMI

向作者/读者索取更多资源

Aims Studies of children with diabetes up to the age of 15 years report deteriorating glycaemic control in the early teenage years. The aim was to investigate glycaemia and body mass index in older teenagers and young adults. Method A Scottish, regional, population-based, cross-sectional study of 255 young people (117 female, 138 male) with Type 1 diabetes, aged 15-25 years (mean +/- SD 19.8 +/- 2.8 years, diabetes duration: 8.8 +/- 5.4 years) registered on a diabetes database. Glycaemic control, body mass index (BMI) and insulin regimens were assessed in three age groups [group 1 (n = 96) 15-18 years; group 2 (n = 74) 18.1-22 years; and group 3 (n = 85) 22.1-25 years]. Results Subjects in the oldest age group had a significantly lower mean HbA(1c) than those in the youngest age group (8.8 +/- 1.7 vs. 9.9 +/- 1.9%; P < 0.001). Mean BMI was higher in group 3 (25.2 +/- 3.4 kg/m(2)) compared with group 1 (23.9 +/- 3.1 kg/m(2); P < 0.001). HbA(1c) levels were higher in the younger subjects and women. Lower HbA(1c) levels were associated with a higher BMI (r = -0.324, P < 0.001) in men only. Overall, 74% took three or more injections a day, of whom 60% were on basal/bolus therapy. The proportion on basal/bolus insulin therapy increased with age and duration of diabetes. Conclusion Compared with adolescents, young adults with Type 1 diabetes have better glycaemic control and higher BMI. This was associated with lower insulin requirements.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Factors associated with stillbirth in women with diabetes

Sharon T. Mackin, Scott M. Nelson, Sarah H. Wild, Helen M. Colhoun, Rachael Wood, Robert S. Lindsay, S. Gribble, A. Abubaker, A. Barnett, C. Fischbacher, E. Pearson, G. Leese, J. Chalmers, J. Mcknight, J. Petrie, N. Sattar, O. Wu, R. McCrimmon, S. Philip, S. Cunningham

DIABETOLOGIA (2019)

Article Medicine, General & Internal

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study

Andreas Ochs, Stuart McGurnaghan, Mike W. Black, Graham P. Leese, Sam Philip, Naveed Sattar, Caroline Styles, Sarah H. Wild, Paul M. McKeigue, Helen M. Colhoun

PLOS MEDICINE (2019)

Article Endocrinology & Metabolism

Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland

Anita Jeyam, Stuart J. McGurnaghan, Luke A. K. Blackbourn, John M. McKnight, Fiona Green, Andrew Collier, Paul M. McKeigue, Helen M. Colhoun

DIABETES CARE (2020)

Article Endocrinology & Metabolism

Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017

Joseph E. O'Reilly, Luke A. K. Blackbourn, Thomas M. Caparrotta, Anita Jeyam, Brian Kennon, Graham P. Leese, Robert S. Lindsay, Rory J. McCrimmon, Stuart J. McGurnaghan, Paul M. McKeigue, John A. McKnight, John R. Petrie, Sam Philip, Naveed Sattar, Sarah H. Wild, Helen M. Colhoun

DIABETOLOGIA (2020)

Article Endocrinology & Metabolism

Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland

Thomas M. Caparrotta, Luke A. K. Blackbourn, Stuart J. McGurnaghan, John Chalmers, Robert Lindsay, Rory McCrimmon, John McKnight, Sarah Wild, John R. Petrie, Sam Philip, Paul M. McKeigue, David J. Webb, Naveed Sattar, Helen M. Colhoun

DIABETES CARE (2020)

Article Endocrinology & Metabolism

Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland

Anita Jeyam, Fraser W. Gibb, John A. McKnight, Brian Kennon, Joseph E. O'Reilly, Thomas M. Caparrotta, Andreas Hohn, Stuart J. McGurnaghan, Luke A. K. Blackbourn, Sara Hatam, Rory J. McCrimmon, Graham Leese, Robert S. Lindsay, John Petrie, John Chalmers, Sam Philip, Sarah H. Wild, Naveed Sattar, Paul M. McKeigue, Helen M. Colhoun

Summary: The study aimed to evaluate the use of continuous subcutaneous insulin infusion (CSII) in individuals with type 1 diabetes in Scotland and its impact on glycaemic control. Results showed CSII treatment led to significant reductions in HbA(1c) levels, particularly in those with high baseline levels, and was also associated with lower rates of DKA and SHH events.

DIABETOLOGIA (2021)

Article Endocrinology & Metabolism

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

Stuart J. McGurnaghan, Amanda Weir, Jen Bishop, Sharon Kennedy, Luke A. K. Blackbourn, David A. McAllister, Sharon Hutchinson, Thomas M. Caparrotta, Joseph Mellor, Anita Jeyam, Joseph E. O'Reilly, Sarah H. Wild, Sara Hatam, Andreas Hoehn, Marco Colombo, Chris Robertson, Nazir Lone, Janet Murray, Elaine Butterly, John Petrie, Brian Kennon, Rory McCrimmon, Robert Lindsay, Ewan Pearson, Naveed Sattar, John McKnight, Sam Philip, Andrew Collier, Jim McMenamin, Alison Smith-Palmer, David Goldberg, Paul M. McKeigue, Helen M. Colhoun

Summary: The study aimed to compare the risk of fatal or critical care unit-treated COVID-19 between people with and without diabetes, and developed a predictive model. Results showed that people with diabetes had a higher risk of developing the disease, with several related factors, and the predictive model demonstrated good accuracy.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Foot Ulcer and Risk of Lower Limb Amputation or Death in People With Diabetes: A National Population-Based Retrospective Cohort Study

Rosemary C. Chamberlain, Kelly Fleetwood, Sarah H. Wild, Helen M. Colhoun, Robert S. Lindsay, John R. Petrie, Rory J. McCrimmon, Fraser Gibb, Sam Philip, Naveed Sattar, Brian Kennon, Graham P. Leese

Summary: This study investigated the incidence of foot ulceration and amputation-free survival in people with diabetes, finding that foot ulceration was associated with lower amputation-free survival rates. Risk factors for foot ulceration in diabetes patients included social deprivation, mental illness, and being underweight.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study

Anita Jeyam, Fraser W. Gibb, John A. McKnight, Joseph E. O'Reilly, Thomas M. Caparrotta, Andreas Hohn, Stuart J. McGurnaghan, Luke A. K. Blackbourn, Sara Hatam, Brian Kennon, Rory J. McCrimmon, Graham Leese, Sam Philip, Naveed Sattar, Paul M. McKeigue, Helen M. Colhoun

Summary: Results of the study showed that for type 1 diabetes patients using flash monitors, there was a significant reduction in HbA(1c) levels and a noticeable decrease in DKA rates after FM initiation. The use of FM has important implications for improving blood sugar management in diabetic patients.

DIABETOLOGIA (2022)

Article Multidisciplinary Sciences

Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018

Andreas Hohn, Stuart J. McGurnaghan, Thomas M. Caparrotta, Anita J. Jeyam, Joseph E. O'Reilly, Luke A. K. Blackbourn, Sara J. Hatam, Christian Dudel, Rosie J. R. Seaman, Joseph Mellor, Naveed M. Sattar, Rory J. M. McCrimmon, Brian Kennon, John R. Petrie, Sarah Wild, Paul M. McKeigue, Helen M. Colhoun

Summary: This study examines the impact of socioeconomic disparities on life expectancy and years lived without complications among individuals with type 1 diabetes in Scotland. The results demonstrate that patients with higher levels of socioeconomic deprivation experience shorter life expectancy and fewer years without complications. The study highlights the importance of tailored support for individuals from low socioeconomic backgrounds in diabetes management and complication prevention.

PLOS ONE (2022)

Article Medicine, General & Internal

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort - a population-based cohort of people with diabetes in Scotland

Stuart J. McGurnaghan, Luke A. K. Blackbourn, Thomas M. Caparrotta, Joseph Mellor, Anna Barnett, Andy Collier, Naveed Sattar, John McKnight, John Petrie, Sam Philip, Robert Lindsay, Katherine Hughes, David McAllister, Graham P. Leese, Ewan R. Pearson, Sarah Wild, Paul M. McKeigue, Helen M. Colhoun

Summary: The SDRN-National Diabetes Dataset is a research platform that combines electronic health record data for diabetes research in Scotland. It has been used for various studies on disease burden, drug safety, and clinical decision making.

BMJ OPEN (2022)

Article Endocrinology & Metabolism

Type 1 diabetes incidence in Scotland between 2006 and 2019

India Thomson, Niall Anderson, Louise Bath, Sarah Kiff, Chris Patterson, Sam Philip, Norman Waugh, Sarah H. H. Wild

Summary: This study aimed to investigate the incidence of type 1 diabetes in Scotland from 2006 to 2019. Annual cross-sectional studies were conducted using data from SCI-DC. The results showed that the incidence of type 1 diabetes remained stable during the study period and varied by age, sex, and socio-economic status.

DIABETIC MEDICINE (2023)

Review Endocrinology & Metabolism

Effect of the dual sodium-glucose co-transporter-1 and-2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials

Maria Anna Bantounou, Panagiotis Sardellis, Rosa Thuemmler, Daniel Black Boada, Justyna Kaczmarek, Ribeya Mahmood, Josip Plascevic, Sam Philip

Summary: This study investigated the renal safety profile of sotagliflozin, a new inhibitor of sodium-glucose co-transporter-1 and -2, in patients with type 1 and type 2 diabetes. The results showed that sotagliflozin did not adversely affect renal function and did not change the risk of key renal outcomes, even in patients with pre-existing renal impairment.

DIABETES OBESITY & METABOLISM (2023)

Article Health Care Sciences & Services

User-Centered Design of A Novel Risk Prediction Behavior Change Tool Augmented With an Artificial Intelligence Engine (MyDiabetesIQ): A Sociotechnical Systems Approach

Cathy Shields, Scott G. Cunningham, Deborah J. Wake, Evridiki Fioratou, Doogie Brodie, Sam Philip, Nicholas T. Conway

Summary: This study aims to develop a user-centered digital health intervention tool for predicting diabetes complications risk and providing personalized support. Through methods such as focus groups and user testing, researchers collected and analyzed user opinions and feedback to improve the tool's usability and user engagement. The results indicate that considering user needs and opinions throughout the development process can enhance the effectiveness of the tool and have a positive impact on users' self-management and health outcomes.

JMIR HUMAN FACTORS (2022)

Meeting Abstract Endocrinology & Metabolism

Real-world user acceptability of the FreeStyle Libre: A pilot study on human factors and technology acceptance

A. Gautam, S. Philip, M. J. MacLeod, A. Cadzow, A. J. Graveling

DIABETIC MEDICINE (2020)

暂无数据